Although the new cytochemical assays of hormones have many important advantages over radioimmunoassay they are unlikely to be of use to clinical biochemists because of their remarkably low through-put. This has been overcome by using a new approach to bioassay in which the hormone is allowed to act on sections of the target organ. The many practical obstacles to this approach have been investigated and overcome. Consequently it is now possible to assay ACTH in many samples of plasma simultaneously and at a fraction of the time required by the previously described cytochemical methods, while yet retaining the remarkable sensitivity and accuracy of these methods.
Radioimmunoassay has become accepted as the main method for the routine assay of polypeptide hormones in clinical biochemistry. First developed by Yalow and Berson (1960) for assaying insulin, it has now been used for many polypeptide hormones and, more recently, for the estimation of other hormones. As an example, the present discussion will take the assay of adrenocorticotrophin (ACfH). Prior to radioimmunoassay, the bioassays (for example, Sayers, Sayers and Woodbury, 1948; Lipscomb and Nelson, 1962; Vernikos-Danellis, Anderson and Trigg, 1966) were highly complex, time-consuming, and costly in the large numbers of animals required. Their sensitivity was poor, measuring down to approximately 100 pgjml; the concentration of ACTH in normal subjects varies from about 60 pgjml at 8.00 a.m. to 12 pgjml at 8.00 p.m, In contrast, radioimmunoassay could measure as Ii ttle as 40 pgjml (Landon and Greenwood 1968 )and, with the more recent improvements, under ideal conditions it may measure as little as 10 pgjml, after extraction of8 m1 ofplasma. Its great advantages were that large numbers could be handled in a single batch; that it was not costly in animals; and, being independent of variation between different animals, it was remarkably precise in that its coefficient of variability was of the order of 10%. Because it depends on the immunological recognition of the ACfH polypeptide, or of a part of it, the method was expected to be highly specific.
However, over the past two years, it has become increasingly apparent that radioimmunoassay had severe limitations. Thus firstly, it will treat ACfHlike polypeptides as if they were ACfH, even when they have no biological ACTH-activity (Besser et al., 1971) . This can yield highly misleading results, particularly when there is rapid flux in the concen-43 tration of ACTH in the blood; presumably under these conditions radioimmunoassay assays degraded fragments of ACTH (Besser et al., 1971; Fleisher, Glass, Daly and Chayen, in press) . Secondly, the precision of the method becomes very poor at low levels of ACTH and it cannot detect very low levels (below 10 pgjml). Thirdly, it requires a considerable volume of blood if a time-course of events is to be studied, as when investigating the episodic secretion of ACTH.
For all these reasons, the development of the new cytochemical bioassay techniques was of some interest. The first of these, for the bioassay of ACfH (Daly, Loveridge, Bitensky and Chayen, 1972; Chayen, Loveridge and Daly, 1972) detected as little as 0.05 pg of ACTHjml of plasma with a precision of about ± 15 %. This meant that normal and even sub-normal levels of ACTH could be measured in plasma which had been diluted 1:100 or even 1:1000, so that very little blood was taken for each sample. Moreover, this technique measured only biologically active ACTH (Fleisher et al., 1973) . In comparative tests against radioimmunoassay and the older Lipscomb-Nelson bioassay, all methods gave comparable results over the higher concentrations of ACfH, but only the cytochemical bioassay could measure below 5 pgjml .
The principle underlying cytochemical bioassay is the measurement of a critical biochemical change induced by the hormone when it acts on the cells of its target organ, maintained in vitro and hence free from the hormonal influence of the animal. The high sensitivity of these assays depends largely on the use of scanning and integrating microdensitotemtry for measuring the chemical change, so that the change, magnified through a microscope system and by means of a multiple-stage photomultiplier, can be measured in the target cells alone, uninfluenced by the lack of change in the supporting tissue.
Cytochemical bioassay has now been applied to the estimation of thyroid stimulating hormone (Alaghband-Zadeh. Bitensky, Daly. Lawton and Chayen, 1973) ; of luteinising hormone (Rees, Holdaway. Kramer. McNeilly and Chard. 1973) ; and of gastrin (Loveridge. personal communication). The range of biochemical reactions and of target cells used in these studies makes it seem probable that cytochemical bioassay may be applicable to the assay of many. if not most. hormones irrespective of their composition.
This form of bioassay, although of considerable theoretical interest, is unlikely to be usable in routine clinical biochemistry laboratories. Because it is a 'within-animal' assay, each sample requires four segments of the target organ to be tested against graded concentrations of the hormone to produce a standard curve and two segments for two dilutions of the test plasma. Consequently the assay of each plasma sample requires about two days. This drawback could be overcome if. instead of segments (e.g. 15 mm") of the target organ. one could use thin slices or sections. In this case, some 500 sections (20 fLm thick) of the adrenal glands of one guinea pig could be used. From these. eight sections would be required for testing (in duplicate) the response of these adrenal cortex cells to four graded concentrations of ACTH, and the rest could be used for 100-200 assays.
The reason this obvious step had not been taken was the great amount of evidence that sections of fresh tissue readily disintegrate when placed in the physiological type of medium needed for testing the response of cells to hormones (for example. Altman and Chayen, 1965; Jones. 1965 ). On the other hand there is also some evidence (Chayen and Bitensky, 1968; Butcher, 1971 ) that this disintegration can be prevented by incorporating a sufficient concentration of a suitable colloid-stabiliser in the physiological medium.
This communication presents evidence that the advantages of the cytochemical bioassay can be retained when suitably protected sections of the target organ are exposed to the effective hormone, in this case ACTH. As a result, large batches of plasma samples can be assayed for their ACTHcontent, which should make this type of assay suitable for use in routine clinical biochemistry.
ApPARATUS AND REAGENTS

Reaction vessels
To facilitate the simultaneous handling of a large number of sections mounted on glass sides, a simple apparatus has been constructed ( Fig. I ). It consists of three components, all made in Perspex. The first is an oblong trough, divided into compart-FIR. I.-Part of the simple sllde-handllng apparatus. showing the lid fitted on to the trough. The slides, clipped on to the lid, are Immersed In the appropriate reaction medium containing either standard ACTH or plasma. ments each of which is I cm in breadth. The second forms a lid to this trough. It has small metal clips arranged so that they fit to the centre of each compartment. The third is another oblong trough, of the same size as the first but not compartmentalised; this acts as a staining trough in which all sections are immersed together in the common staining solution.
The sections (see below) are gripped back-to-back in the metal clips so that, when the lid is lowered onto the first trough, two sections (duplicated for any given treatment) lie in each compartment. Each compartment contains the physiological reaction medium (see below) containing either one of the graded concentrations of ACTH (3rd International Working Standard), or one of the diluted samples of plasma.
PROCEDURE
ReQgC'IIfs
Culture medium. To Trowell T8 medium (Flow Laboratories. Irvine, Ayshire) was added to 10 3 M sodium ascorbate (Halewood Chemicals Ltd. 
Preparation of tissue
As in the now established cytochemical method both adrenal glands are removed from a guinea-pig (Hartley strain, 500 g body weight; sex immaterial) and each is cut into three roughly equal segments. Each is maintained in Trowell non-proliferative organ culture (Trowell, 1959) for 5 h. The objects of this manoeuvre are (l) to remove the adrenal tissue from the hormonal influence of the guinea-pig;
(2) to allow it to recover from the trauma of excision from the body; and (3) to ensure that the cells have a sufficient concentration of ascorbate (see Chayen et al., 1972) .
Priming the tissue
At the end of 5 h the culture medium is removed and replaced by fresh T-8 ascorbate medium which contains 0.0005 pg of ACfH/ml (0.5 fg/ml). This fluid is poured over the adrenal tissue, which is removed after 4 min. exposure to this concentration of ACfH. This procedure ensures that the response of the tissue, in section, is the same as that of the segments-namely, down to 0.005 pg of ACfH/ml (see below).
Section procedure
After the 4-min. exposure to 0.5 fg of ACfH/ml the tissue is chilled to -70°C in n-hexane for 0.5-1 min. It is then transferred to a cold tube, also at -70°C, and stored at -70°C until used. (Preferably the tissue should be used within three days as the response becomes less with increasing storage beyond this time.) The tissue is then cut at 20 p.m with an automatic microtome in a Bright's cryostat, with the ambient temperature at -25°C and the knife cooled to -70°C by having its haft packed around with solid carbon dioxide. These methods have been discussed fully by Chayen and Bitensky (1968) and by Chayen, Bitensky and Butcher (1973) .
The sections are then air-dried at room tempera-4S ture and clipped into the lid of the reaction vessel Each compartment is filled with its appropriate solution; the lid is then closed, so exposing each pair of sections to the required concentration of ACTH or of plasma for 1 min. The lid is then raised and placed on the staining trough. This stops the action of the hormone and allows the reducing potency of the cells to be expressed as the amount of dye produced. The staining is allowed to proceed for 5 min; the staining mixture is replaced by a freshly prepared solution and staining is allowed to proceed for a further 5 min. This staining procedure is then repeated, giving a total of 15 min (three fresh baths) staining time. The sections are then rinsed in tap water, air-dried at room temperature, cleared in xylene, and mounted in Merciamount. The mounted sections should be kept in the dark because the stain fades in strong light. The amount of stain, per unit standard area of microscopic field of the zona reticularis, is measured by means of a Vickers M85 scanning and integrating microdensitometer fitted with red-sensitive photomultipliers (Alaghband-Zadeh et al., 1972) . The absorption is read at 640 nm; for this purpose a x 20 objective is used, with a large field mask in the microdensitorneter-system, so that some 5-10 cells are measured in each field. The instrument reads the relative absorption per field; this value is converted into mean integrated extinction (in absolute terms) by means of a conversion factor determined for the instrument. (For fuller discussion of such conversion see Bitensky, Butcher and Chayen, 1973 .)
Assay procedure
The sections which have been treated with graded concentrations of the 3rd International Working Standard ACfH are measured first. From these is obtained a calibration graph which relates the integrated extinction (equivalent to the amount of stain and hence of reducing potency) to the concentration of ACfH. By the use of this graph (Fig. 2) , the amount of stain in the zona reticularis of the sections which have been treated with the unknowns can then be converted to the concentration of ACfH in these plasmas.
The measurement of the standard graph and of nine unknown samples, all measured at two concentrations and with all measurements made in duplicate, takes between 3 and 4 h. Together with the maintenance culture, sectioning, staining and measurement, nine assays can be done readily in one and a half days; the normal cytochemical method requires this time for one assay. Moreover, many more than nine assays could be done simultaneously by this section-method with only slight extension of the time taken. For example, 18 assays would take 6 h to measure and hence could be done in two days.
only maintained for 5 h and were not primed with ACTH, the cells in the sections no longer responded to low concentrations of ACTH-for example, to 0.005 pgjml. Thus the unprimed tissue lost sensitivity by a factor of 10 ( Fig. 3) . This was recovered in the
Experimental basis of the procedure
To establish that this response of sections to ACTH could be used as a method of assay a number of studies had to be made. In summary, they are:
(1) Sections immersed directly in T8 medium almost disintegrated, as seen by phase-contrast microscopy. They did not respond in a meaningful fashion to different concentrations of ACTH and there was great variability between duplicate sections. Some colloidal stabilisers, such as Dextran, totally inhibited the response of the cells to ACTH, as did high concentrations of the polypeptide 5115. The best preservation of the sections, and the best response to ACTH, was found in sections protected with 5 % (wjv) of polypeptide 5115, which is a degradation product of collagen.
(2) Sections of 10 f-Lm thickness showed little response to ACTH, the optimal response being found when the sections were 20 f-Lm thick, which is the size of the larger cells of the zona reticularis in the guinea-pig adrenal gland.
(3) If the segments of the adrenal gland were rl 5"5 30 " 20 PI ACTH Fig. 3.- The effect of priming. The solid line showing the response (integrated extinction x 10 2 ) in four sections exposed to graded concentrations of ACTH; this tissue has not been primed and is unable to distinguish between O.OS and O.OOS pg/ml. In contrast, the sections from the primed tissue show a linear response from 0.005 to 5 pg/ml. (Arrows indicate the values of duplicate sections exposed to each concentration marked.) sections from adrenal tissue which had been 'primed' by 4 min. exposure to 0.5 fg of ACTHjml.
(4) When the sections were exposed to either graded concentrations of ACTH, or to dilutions of' plasma, dissolved in T8 medium alone, the timecourse of the response of the cells was too rapid for a convenient assay. The addition of 10-3 M sodium ascorbate to the T8 medium gave a better activity: time response, and improved the reproducibility between duplicate sections.
VALIDATION
Comparison with segment bioassay
A number of plasma samples have been measured by the section bioassay, described above, and by the segment method. Generally the two methods were used by two different workers. Good agreement between values has been obtained in all cases. As an example, samples were taken from a dexamethasone-suppressed subject at six times, just before and after intravenous injection of 120 ng of a substituted 1-18 ACTH. Each sample was assayed for ACTH by the section method and by the segment procedure (by Mr. D. Chambers). The results were in close agreement; both methods assayed the concentration of ACTH (35 pgjml) expected from the blood volume of this particular subject.
Recovery. A plasma was assayed as containing 70 pg of ACTH per mI (75 and 65 pgjml when measured in 1:1000 and 1:100 dilution). To one sample of this plasma, 50 pg of ACTHjml were added; to the other, 100 pgjml were added. The two plasma samples then assayed at 120 and at 170 pgfml, so showing complete recovery.
Reproducibility of measurement and of the response of the sections
A number (5 or 6) of sections was exposed to each of four graded concentrations of ACTH in order to test the reproducibility of replicate measurements of the response to each concentration. The coefficient of variation was 4 % irrespective of whether the replicate sections were treated with 0.005, 0.05, 0.5, or 5 pg of ACTHjml. Other sections were exposed to a plasma which had been diluted either I: I00 or I: 1000. From all these results, the index of precision and the fiducial limits of this particular assay were calculated. The index of precision was 0.112; in four other studies, the index of precision varied from 0.03 to 0.11. The fiducial limits (p = 0.95) of this assay and of a second assay were 79-126 %.
It is apparent, therefore, that the reproducibility 47 and precision of this section-assay is as good as that of the segment assay.
Specificity
To a large extent, the specificity of the sectionassay should be that of the segment-assay. As a further check, a plasma was first assayed at two dilutions; the mean value was 23 pg of ACTHjmI. To this plasma, diluted 1 :100, an excess of an antibody to ACTH was added (Wellcome anti-human ACTH serum, RD 05-06). This plasma then assayed at J.5 pgjmI.
DISCUSSION
It has been shown, therefore, that fresh, unfixed sections of guinea-pig adrenal gland can be made to respond in a regular fashion to graded concentrations of ACTH very much as do whole segments of the adrenal tissue. To achieve this response it is necessary firstly, that the sections are cut at 20 j1.m, so that the thickness of the section is equal to the largest dimension of the large cells of the zona reticularis, and secondly, that the sections are protected from disintegrating in the ACTH-solution by incorporating into it a suitable concentration of a colloid-stabiliser (namely, 5 % polypeptide 5115).
The full response-that is, down to 5 fgjml-also requires that the adrenal tissue, before sectioning should have been maintained in vitro for 5 h, as in the segment assay, and then to have been 'primed' by exposure to 0.5 fg of ACTHjml of culture medium for 4 min.
When all these conditions are met, sections of the adrenal gland respond to ACTH very much as do the segments of the gland in the segment assay. They respond more rapidly, presumably owing to the fact that the hormone does not have to diffuse through a compact tissue to activate all the responsive cells.
Consequently it is now possible to assay to many samples of plasma simultaneously. In the present series of studies nine assays have been done together with the four points required for the calibration graph. Without undue haste, these assays can be completed in one and a half days; they would have taken at least two weeks if done by the segmentmethod. This means that the cytochemical bioassay of ACTH has now become a feasible proposition in routine clinical biochemistry provided it is done by the section-technique. Moreover, it is likely that the use of sections will not be restricted to the bioassay of ACTH. As it has been shown that suitably protected sections of a target tissue can be made to respond to the specific hormone in a regular manner it is probable that the cytochemical bioassay of other hormones, such as TSH, could be similarly modified.
Now that a section-assay has brought the cytochemical bioassay procedure within the scope of routine laboratories, some discussion of relative costs may be helpful. If one uses an Amersham radioimmunoassay kit for assaying ACfH the cost works out at about £2 for each assay; the capital cost (for a gamma-counter) is about £6000. For the cytochemical assay, the capital cost is similar (£4500 for the microdensitometer and £700 for the cryostat). The 'consumable apparatus' cost of the sectionassay is made up mainly of the cost of one guinea-pig (125p), of the culture medium, and the gas. If only nine assays are done the cost will be about 3Op; if the full capacity of the adrenal tissue is used, namely about 400 sections, then each assay would cost about 5p. I am deeply indebted to Dr. J. R. Daly, under whose direction this work has been done. I gratefully acknowledge the help and facilities given me by Dr. Lucille Bitensky and Dr. J. Chayen in the Division of Cellular Biology of the Kennedy Institute of Rheumatology.
